Literature DB >> 17091248

Adverse effects of drug therapies on male and female sexual function.

Th Stadler1, M Bader, S Uckert, M Staehler, A Becker, C G Stief.   

Abstract

Sexual dysfunctions (SD) are adverse effects of common drug therapies that have rarely been considered in investigations so far. Possibly it is barely known that many widespread and frequently prescribed medications and drug therapies can have significant impact on vascular and nerval processes as well as on endocrinologic and psychoneuroendocrinologic systems and therefore can influence sexual functions. Impotence and disorders of the erectile function can mainly be caused by antidopaminergic mechanisms, whereas ejaculatory disorders and anorgasmia often can be explained by antiserotoninergic effects. Anticholinergic and adrenoloytic agents can also cause a particular impairment of erectile functions. The following considerations will show that the detection and treatment of SD (also in women!) should be given much more attention since drug-induced SDs occur predominantly in indications where a SD itself can be a symptom of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 17091248     DOI: 10.1007/s00345-006-0136-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   3.661


  29 in total

Review 1.  Neuroleptic medication and sexuality: the forgotten aspect of education and care.

Authors:  A Higgins; P Barker; C M Begley
Journal:  J Psychiatr Ment Health Nurs       Date:  2005-08       Impact factor: 2.952

Review 2.  Effects of antihypertensive agents on sexual function.

Authors:  R J Weiss
Journal:  Am Fam Physician       Date:  1991-12       Impact factor: 3.292

3.  Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.

Authors:  Maurizio Fava; H George Nurnberg; Stuart N Seidman; Willis Holloway; Susan Nicholas; Li-Jung Tseng; Vera J Stecher
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

Review 4.  Hypertension, antihypertensive therapy, and erectile dysfunction.

Authors:  Athanasios G Papatsoris; Panagiotis G Korantzopoulos
Journal:  Angiology       Date:  2006 Jan-Feb       Impact factor: 3.619

Review 5.  Prevalence of antidepressant-associated erectile dysfunction.

Authors:  Raymond C Rosen; Humberto Marin
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

6.  Sexual dysfunction due to antihypertensive agents.

Authors:  J G Stevenson; G S Umstead
Journal:  Drug Intell Clin Pharm       Date:  1984-02

7.  Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.

Authors:  Bruce J Kinon; Jonna Ahl; Hong Liu-Seifert; Gerald A Maguire
Journal:  Psychoneuroendocrinology       Date:  2006-02-20       Impact factor: 4.905

8.  Spironolactone and endocrine dysfunction.

Authors: 
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

9.  Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study.

Authors:  Pedro Aranda; Luis M Ruilope; Carlos Calvo; Manuel Luque; Antonio Coca; Angel Gil de Miguel
Journal:  Am J Hypertens       Date:  2004-02       Impact factor: 2.689

Review 10.  Effects of alpha(1)-adrenoceptor antagonists on male sexual function.

Authors:  Marleen M van Dijk; Jean J M C H de la Rosette; Martin C Michel
Journal:  Drugs       Date:  2006       Impact factor: 9.546

View more
  6 in total

1.  Steps in the investigation and management of low semen volume in the infertile man.

Authors:  Matthew Roberts; Keith Jarvi
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 2.  [Influence of drugs on urological diseases].

Authors:  P A Thürmann
Journal:  Urologe A       Date:  2016-03       Impact factor: 0.639

3.  Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.

Authors:  Michael J Crawford; Lavanya Thana; Rachel Evans; Alexandra Carne; Lesley O'Connell; Amy Claringbold; Arunan Saravanamuthu; Rebecca Case; Jasna Munjiza; Sandra Jayacodi; Joseph G Reilly; Elizabeth Hughes; Zoe Hoare; Barbara Barrett; Verity C Leeson; Carol Paton; Patrick Keown; Sofia Pappa; Charlotte Green; Thomas Re Barnes
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

4.  Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers.

Authors:  Elisabet Ekman; Staffan Hägg; Anders Sundström; Viktoria Werkström
Journal:  Drug Healthc Patient Saf       Date:  2010-03-29

5.  Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.

Authors:  C Derzko; S Elliott; W Lam
Journal:  Curr Oncol       Date:  2007-12       Impact factor: 3.677

6.  Barriers to the management of sexual dysfunction among people with psychosis: analysis of qualitative data from the REMEDY trial.

Authors:  Lavanya J Thana; Lesley O'Connell; Alexandra Carne-Watson; Abhishek Shastri; Arunan Saravanamuthu; Natasha Budhwani; Sandra Jayacodi; Verity C Leeson; Jasna Munjiza; Sofia Pappa; Elizabeth Hughes; Joe Reilly; Mike J Crawford
Journal:  BMC Psychiatry       Date:  2022-08-12       Impact factor: 4.144

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.